New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
07:09 EDTALIMAlimera Sciences resubmits NDA for Iluvien
Alimera Sciences has resubmitted its New Drug Application for Iluvien to the FDA. At this time, Alimera awaits the FDA's acceptance of the resubmission and a Prescription Drug User Fee Act date.
News For ALIM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 28, 2014
09:11 EDTALIMAlimera Sciences announces agreement with Deerfield for $50M financing
Subscribe for More Information
08:35 EDTALIMAlimera Sciences enters $50M financing agreement
Alimera entered into a Securities Purchase Agreement with Deerfield Management and certain of its affiliates pursuant to which Alimera will issue shares of preferred stock to Deerfield with an aggregate purchase price of approximately $50M upon the satisfaction of certain closing conditions. Alimera has also agreed to issue an additional 124.378 shares of preferred stock as a subscription premium. The preferred stock will be convertible into an aggregate of 8,416,251 shares of Alimera common stock. Alimera plans to use the proceeds for commercial launch of its lead product, ILUVIEN, in the United States, continued marketing efforts in Europe and general corporate purposes.
November 17, 2014
11:46 EDTALIMAlimera Sciences' ILUVIEN receives marketing approval in Ireland
Subscribe for More Information
10:02 EDTALIMOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:55 EDTALIMAlimera Sciences initiated with a Buy at Summer Street
Target $12.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use